Cargando…
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies...
Ejemplares similares
-
Detection of homozygous and hemizygous complete or partial exon deletions by whole-exome sequencing
por: Bigio, Benedetta, et al.
Publicado: (2021) -
Humidification Practices of Extremely Preterm Neonates: A Clinical Survey
por: Rizk, Nina, et al.
Publicado: (2022) -
Multisystem inflammatory syndrome in children related to COVID-19: a systematic review
por: Hoste, Levi, et al.
Publicado: (2021) -
COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events
por: Pergent, Martine, et al.
Publicado: (2023) -
Lymphocyte homeostasis is maintained in perinatally HIV-infected patients after three decades of life
por: Paghera, S., et al.
Publicado: (2019)